QIM
ARRY

Quantitative Investment Management’s Array Biopharma Inc ARRY Stock Holding History

Quantitative Investment Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-21,200
Closed -$516K – 895
2019
Q1 		$516K Buy
+21,200
New +$441K 0.03% 493
2018
Q3 		– Sell
-49,100
Closed -$823K – 990
2018
Q2 		$823K Buy
+49,100
New +$781K 0.02% 524
2017
Q3 		– Sell
-443,700
Closed -$3.71M – 917
2017
Q2 		$3.71M Buy
+443,700
New +$3.63M 0.06% 393
2016
Q2 		– Sell
-16,000
Closed -$47K – 1007
2016
Q1 		$47K Buy
+16,000
New +$47.9K ﹤0.01% 736
2015
Q4 		– Sell
-55,400
Closed -$252K – 918
2015
Q3 		$252K Buy
+55,400
New +$328K 0.02% 568
2015
Q2 		– Sell
-66,400
Closed -$489K – 763
2015
Q1 		$489K Buy
+66,400
New +$473K 0.05% 354

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Quantitative Investment Management's ARRY Position: Q2 2019 in Review

Quantitative Investment Management sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 21,200 shares — an estimated $516K sold.

Quantitative Investment Management first reported a position in ARRY in Q1 2015 and held it in 6 quarters. The position peaked at $3.71M in Q2 2017. 318 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

  • Quantitative Investment Management reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
  • Quantitative Investment Management sold 21,200 Array Biopharma Inc shares in Q2 2019, an estimated $516K.
  • Quantitative Investment Management first reported a position in Array Biopharma Inc in Q1 2015 and held it in 6 quarters.
  • Quantitative Investment Management's Array Biopharma Inc position peaked at $3.71M in Q2 2017.
  • 318 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Quantitative Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.